There is a revolution unfolding in biotech. The confluence of new biological methods like CRISPR, virtually unlimited computational capacity, and machine learning has fundamentally transformed our ability to engineer biology for wide-ranging applications.
Andreessen Horowitz, or a16z, is a venture capital firm that was founded by Marc Andreessen and Ben Horowitz.
Vijay Pande is a Founding General Partner at a16z, where he leads the firm’s investments focused on the cross section of biology and computer science, including areas such as digital therapeutics, cloud biology, and computational medicine.
He joins the podcast to talk about innovation in biotech and healthcare, the biotech startup landscape, the impact of AI, and much more.
Sean’s been an academic, startup founder, and Googler. He has published works covering a wide range of topics from information visualization to quantum computing. Currently, Sean is Head of Marketing and Developer Relations at Skyflow and host of the podcast Partially Redacted, a podcast about privacy and security engineering. You can connect with Sean on Twitter @seanfalconer .
Watch the video episode here
Sponsorship inquiries: sponsor@softwareengineeringdaily.com
The post Biotech Special: a16z and the Biotech Revolution with Vijay Pande appeared first on Software Engineering Daily.
